Proposed Medicare changes could limit access to a highly effective, noninvasive skin cancer therapy for seniors.

Data show that nearly two-thirds of Medicare beneficiaries feel that their coverage completely meets their expectations.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Stories like Tom’s reveal the truth: Medicare Advantage is unapologetically failing its elderly cancer patients. Sick American seniors deserve more than insurance coverage in name only. We ...

In 2023 alone, Medicare Advantage plans fully or partially denied 3.2 million prior authorization requests. No one, especially among folks facing the daily drudgery of fighting cancer, truly ...

A new study reveals that Medigap protection laws significantly affect Medicare plan choices for older adults diagnosed with ...

Medicare Part B covers 80% of outpatient cancer-related services like radiation therapy and chemotherapy after a deductible, with the insured person responsible for the remaining 20%.

Using national Medicare data, we performed retrospective analyses of beneficiaries who had a new cancer diagnosis between 2016 and 2021 and who were at risk of receiving a low-value treatment: ...

Until recently, Medicare patients often faced over $10,000 in yearly out-of-pocket costs for essential oral cancer medications. But with changes to Medicare Part D under the Inflation Reduction ...